首页> 外文期刊>Journal of Medicinal Plants Research >Towards accomplishing the roll back malaria initiative: Phytochemical screening and antimalarial activity of ethanolic leaf extract of Ricinus communis L. (Euphorbiaceae)
【24h】

Towards accomplishing the roll back malaria initiative: Phytochemical screening and antimalarial activity of ethanolic leaf extract of Ricinus communis L. (Euphorbiaceae)

机译:迈向遏制疟疾的举措:蓖麻(Euphorbiaceae)乙醇叶提取物的植物化学筛选和抗疟活性

获取原文
           

摘要

Malaria is a major debilitating disease caused by Plasmodium species and spread by female Anopheles mosquitoes. This research was conducted to determine the efficacy of ethanolic leaf extracts of Ricinus communis L. against Plasmodium berghei (NK65) infection in mice. Phytochemical components of the extract were analyzed and elucidated in order to reveal the constituents with antimalarial potentials. The safety of the extract in the experimental mice was ascertained by determining the median lethal dose (LD50). Result of the phytochemical screening revealed the presence of compounds notable for antimalarial effects such as alkaloids, flavonoids and anthraquinones. From the findings, it was established that a dosage of 141.42 mg/kg of the extract represents the acute lethal dose (LD50) in mice. Hence, three separate doses of the extract (10, 20 and 40 mg/kg) were prepared for the curative test. All the three doses portrayed a remarkable antimalarial activity as compared to the standard reference drug (chloroquine, 5 mg/kg). The extract dosage of 20 mg/kg showed the highest average suppression of 81.6% among the treatments. No significant differences were however observed among the treated groups (P>0.05). On the other hand, a highly significant difference was observed between the treated and control groups (P≤0.001). The leaf extracts of R. communis thus possess antimalarial properties and is therefore recommended as a new candidate for antimalarial drug development.
机译:疟疾是由疟原虫引起的主要衰弱性疾病,并由雌性按蚊传播。进行了这项研究,以确定蓖麻的乙醇叶片提取物对小鼠伯氏疟原虫(NK65)感染的功效。分析和阐明了提取物中的植物化学成分,以揭示具有抗疟疾潜力的成分。通过确定中值致死剂量(LD50)确定提取物在实验小鼠中的安全性。植物化学筛选的结果表明存在抗疟疾作用值得注意的化合物,如生物碱,类黄酮和蒽醌。根据发现,可以确定141.42 mg / kg提取物的剂量代表小鼠的急性致死剂量(LD50)。因此,准备了三个独立剂量的提取物(10、20和40 mg / kg)用于治疗测试。与标准参考药物(氯喹,5 mg / kg)相比,所有三种剂量均表现出显着的抗疟活性。在处理中,提取物剂量为20 mg / kg时显示出最高的平均抑制率,为81.6%。然而,在治疗组之间没有观察到显着差异(P> 0.05)。另一方面,在治疗组和对照组之间观察到非常显着的差异(P≤0.001)。因此,R。com。的叶提取物具有抗疟特性,因此被推荐作为抗疟药物开发的新候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号